Patient Pathfinder: Clinical Trials

Clinical Trial Finder Transthyretin Amyloid Cardiomyopathy Trials

Clinical Trials for Transthyretin Amyloid Cardiomyopathy

Every life-saving or life-extending treatment that's available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.

Clinical trials also give patients a chance to try a treatment before it's approved by the U.S. Food and Drug Administration.

See Locations Near You

There are 33 active Transthyretin Amyloid Cardiomyopathy trials

A Clinical Study to Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Patients With hATTR-PN

Study Type: Interventional Phase 4

Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy

Study Type: Interventional Phase 1

Early Detection of Neuropathy in ATTRv

Study Type: Observational

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

Study Type: Interventional Phase 3

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

Study Type: Observational

carDIo-ttranSSfOrm nucLEar Imaging Study

Study Type: Interventional Phase 3

TEGSEDI Pregnancy Surveillance Program

Study Type: Observational

Exercise Effect on Transthyretin Stability

Study Type: Observational

There are 33 active Transthyretin Amyloid Cardiomyopathy trials

Filter Results

Phase

Study Type

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.

Start Now

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.

Start Now
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider